The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial

BACKGROUND: Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted. METHODS: Multicentre, double-blind, placebo-controlled trial. We aimed to recruit 222 inpatients with severe BPD aged 18 or over,...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, Mike J., Leeson, Verity C., Evans, Rachel, Barrett, Barbara, McQuaid, Aisling, Cheshire, Jack, Sanatinia, Rahil, Lamph, Gary, Sen, Piyal, Anagnostakis, Katina, Millard, Louise, Qurashi, Inti, Larkin, Fintan, Husain, Nusrat, Moran, Paul, Barnes, Thomas R.E., Paton, Carol, Hoare, Zoe, Picchioni, Marco, Gibbon, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058570/
https://www.ncbi.nlm.nih.gov/pubmed/35510087
http://dx.doi.org/10.1177/20451253221090832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058570/
https://www.ncbi.nlm.nih.gov/pubmed/35510087
http://dx.doi.org/10.1177/20451253221090832

Ejemplares similares